Dr Reddys which is currently trading today at 4500 is expected to have huge gains in the coming month.
DR Reddys has approached regulatory authority to get approval for a single-dose Covid vaccine Sputnik and the same is expected to be completed in a couple of weeks.
Dr Reddys in partnership with Russia is planning to manufacture a few million doses of sputnik of both domestic and international use. Currently, India has already approved two covid vaccines Covaxin and Covishield.
Sputnik has a higher advantage than the other two vaccines because it required only a single dose instead of two doses.
Dr Reddys Stock is expected to have good gains and reach 5000 which is a 3 month high for it.